Spike in Medicine Prices Raises Alarm Among Lawmakers

Lawmakers Voice Concern Over Soaring Medicine Costs

The rising cost of medicines in Pakistan has become a pressing issue, drawing sharp criticism from lawmakers. The Senate Standing Committee on Health recently expressed serious concern over the steep increase in drug prices and the growing influence of the formula milk industry.

During a briefing, Health Minister Mustafa Kamal explained that the deregulation of medicine prices—pending for 15 years—was finally implemented. While this policy aimed to align with international practices, it led to significant price hikes for many medicines. The minister emphasized that pharmaceutical companies cannot be forced to operate at a loss, but assured that the ministry is monitoring excessive increases closely.

A detailed report from the Drug Regulatory Authority of Pakistan (Drap) revealed that prices of more than 55% of non-essential medicines have risen. Out of 771 brands, 424 recorded higher prices, with 31 medicines experiencing hikes of over 100%. Meanwhile, 62 brands saw increases between 50% and 100%, while 329 medicines actually became cheaper. Only 18 brands remained unchanged.

Pakistan’s pharmaceutical industry is vast, with 659 companies operating locally and 394 firms importing medicines and vaccines. The sector recorded sales worth Rs1.32 trillion last year, underscoring its economic importance. However, lawmakers stressed that affordability and accessibility must remain priorities, especially for essential medicines.

The committee also addressed the formula milk industry, labeling it a “mafia” profiting at the expense of children’s health. Lawmakers directed Pemra to ensure that advertisements for formula milk carry a clear disclaimer: “There is no better food than mother’s milk.”

This debate highlights the delicate balance between supporting a thriving pharmaceutical industry and ensuring that healthcare remains affordable for ordinary citizens. As medicine prices continue to climb, the government faces mounting pressure to strengthen regulation and protect public health.